Biological assessment of a new ready-to-use hydraulic sealer

다국어 초록 (Multilingual Abstract)

Objectives: This study compared the cytotoxicity, biocompatibility, and tenascin immunolabeling of a new ready-to-use hydraulic sealer (Bio-C Sealer) with MTA-Fillapex and white MTA-Angelus.
Materials and Methods: L929 fibroblasts were cultivated and exposed to undiluted and diluted material extracts. Polyethylene tubes with or without (the control) the materials were implanted into the dorsa of rats. At 7 days and 30 days, the rats were euthanized, and the specimens were prepared for analysis; inflammation and immunolabeling were measured, and statistical analysis was performed (p < 0.05).
Results: MTA-Fillapex exhibited greater cytotoxicity than the other materials at all time points (p < 0.05). The undiluted Bio-C Sealer exhibited greater cytocompatibility at 6 and 48 hours than white MTA-Angelus, with higher cell viability than in the control (p < 0.05). White MTA-Angelus displayed higher cell viability than the control at 24 hours, and the one-half dilution displayed similar results at both 6 and 48 hours (p < 0.05). At 7 days and 30 days, the groups exhibited moderate inflammation with thick fibrous capsules and mild inflammation with thin fibrous capsules, respectively (p > 0.05). At 7 days, moderate to strong immunolabeling was observed (p > 0.05). After 30 days, the control and MTA-Fillapex groups exhibited strong immunolabeling, the white MTA-Angelus group exhibited moderate immunolabeling (p > 0.05), and the Bio-C Sealer group exhibited low-to-moderate immunolabeling, differing significantly from the control (p < 0.05).
Conclusions: Bio-C Sealer and white MTA-Angelus exhibited greater cytocompatibility than MTA-Fillapex; all materials displayed adequate biocompatibility and induced tenascin immunolabeling.

참고문헌 (Reference)

1 Silva GF, "Zirconium oxide and niobium oxide used as radiopacifiers in a calcium silicate-based material stimulate fibroblast proliferation and collagen formation" 50 (50): e95-e108, 2017

2 Han L, "Uptake of calcium and silicon released from calcium silicate-based endodontic materials into root canal dentine" 44 : 1081-1087, 2011

3 Andrade AS, "Tissue response and immunoexpression of interleukin 6 promoted by tricalcium silicate-based repair materials after subcutaneous implantation in rats" 44 : 458-463, 2018

4 Benetti F, "The presence of osteocalcin, osteopontin and reactive oxygen species-positive cells in pulp tissue after dental bleaching" 52 : 665-675, 2019

5 Min KS, "The induction of heme oxygenase-1 modulates bismuth oxide-induced cytotoxicity in human dental pulp cells" 33 : 1342-1346, 2007

6 Reyes-Carmona JF, "The biomineralization ability of mineral trioxide aggregate and Portland cement on dentin enhances the push-out strength" 36 : 286-291, 2010

7 Saraiva JA, "Reduced interleukin-6 immunoexpression and birefringent collagen formation indicate that MTA Plus and MTA Fillapex are biocompatible" 13 : 035002-, 2018

8 Gomes-Filho JE, "Rat tissue reaction to MTA Fillapex®" 28 : 452-456, 2012

9 Monteiro Bramante C, "Presence of arsenic in different types of MTA and white and gray Portland cement" 106 : 909-913, 2008

10 Vitti RP, "Physical properties of MTA Fillapex sealer" 39 : 915-918, 2013

11 Castro-Raucci LMS, "Osteogenic cell response to calcium aluminate-based cement" 50 : 771-779, 2017

12 Costa F, "Osteogenic and angiogenic response to calcium silicate-based endodontic sealers" 42 : 113-119, 2016

13 Titushkin I, "Modulation of cellular mechanics during osteogenic differentiation of human mesenchymal stem cells" 93 : 3693-3702, 2007

14 Salles LP, "Mineral trioxide aggregate-based endodontic sealer stimulates hydroxyapatite nucleation in human osteoblast-like cell culture" 38 : 971-976, 2012

15 Fonseca TS, "Mast cells and immunoexpression of FGF-1 and Ki-67 in rat subcutaneous tissue following the implantation of Biodentine and MTA Angelus" 52 : 54-67, 2019

16 Kebudi Benezra M, "Interfacial characteristics and cytocompatibility of hydraulic sealer cements" 44 : 1007-1017, 2018

17 Demirkaya K, "In vivo evaluation of the effects of hydraulic calcium silicate dental cements on plasma and liver aluminium levels in rats" 124 : 75-81, 2016

18 Zhou HM, "In vitro cytotoxicity of calcium silicate-containing endodontic sealers" 41 : 56-61, 2015

19 Zarrabi MH, "Immunohistochemical expression of fibronectin and tenascin in human tooth pulp capped with mineral trioxide aggregate and a novel endodontic cement" 37 : 1613-1618, 2011

20 Piva E, "Immunohistochemical expression of fibronectin and tenascin after direct pulp capping with calcium hydroxide" 102 : e66-e71, 2006

21 Moradi S, "Immunohistochemical evaluation of fibronectin and tenascin following direct pulp capping with mineral trioxide aggregate, platelet-rich plasma and propolis in dogs’ teeth" 10 : 188-192, 2015

22 International Organization for Standardization (ISO), "ISO 10993-6: Biological evaluation of medical devices - Part 6: Testes for local effects after implantation"

23 International Organization for Standardization (ISO), "ISO 10993-5: Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity"

24 Bernabé PF, "Histological evaluation of MTA as a root-end filling material" 40 : 758-765, 2007

25 Cintra LTA, "Evaluation of the cytotoxicity and biocompatibility of new resin epoxy-based endodontic sealer containing calcium hydroxide" 43 : 2088-2092, 2017

26 Zordan-Bronzel CL, "Evaluation of physicochemical properties of a new calcium silicate-based sealer, Bio-C Sealer" 45 : 1248-1252, 2019

27 Grossman LI, "Endodontic practice" Lea & Febiger 1982

28 Shie MY, "Effects of altering the Si/Ca molar ratio of a calcium silicate cement on in vitro cell attachment" 45 : 337-345, 2012

29 Cintra LTA, "Cytotoxicity, biocompatibility, and biomineralization of the new high-plasticity MTA material" 43 : 774-778, 2017

30 Benetti F, "Cytotoxicity, biocompatibility and biomineralization of a new ready-for-use bioceramic repair material" 30 : 325-332, 2019

31 Silva EJ, "Cytotoxicity profile of endodontic sealers provided by 3D cell culture experimental model" 27 : 652-656, 2016

32 Vouzara T, "Cytotoxicity of a new calcium silicate endodontic sealer" 44 : 849-852, 2018

33 Collado-González M, "Cytotoxicity of GuttaFlow Bioseal, GuttaFlow2, Mta Fillapex, and Ah Plus on human periodontal ligament stem cells" 43 : 816-822, 2017

34 Hirschman WR, "Cytotoxicity comparison of three current direct pulp-capping agents with a new bioceramic root repair putty" 38 : 385-388, 2012

35 Jung S, "Cytotoxic effects of four different root canal sealers on human osteoblasts" 13 : e0194467-, 2018

36 Lessa FC, "Cytotoxic effects of White-MTA and MTA-Bio cements on odontoblast-like cells (MDPC-23)" 21 : 24-31, 2010

37 Chiang TY, "Comparative physicochemical and biocompatible properties of radiopaque dicalcium silicate cement and mineral trioxide aggregate" 36 : 1683-1687, 2010

38 Thesleff I, "Changes in the distribution of tenascin during tooth development" 101 : 289-296, 1987

39 Victoria-Escandell A, "Cellular responses in human dental pulp stem cells treated with three endodontic materials" 2017 : 8920356-, 2017

40 Saghiri MA, "Calcium silicate-based cements and functional impacts of various constituents" 36 : 8-18, 2017

41 Demirkaya K, "Brain aluminium accumulation and oxidative stress in the presence of calcium silicate dental cements" 36 : 1071-1080, 2017

42 Garcia Lda F, "Biocompatibility of new calcium aluminate cement: tissue reaction and expression of inflammatory mediators and cytokines" 40 : 2024-2029, 2014

43 Cosme-Silva L, "Biocompatibility and immunohistochemical evaluation of a new calcium silicate-based cement, Bio-C Pulpo" 52 : 689-700, 2019

44 Cosme-Silva L, "Biocompatibility and biomineralization ability of Bio-C Pulpecto. A histological and immunohistochemical study" 29 : 352-360, 2019